health care
Industries

Healthcare M&A

CRA experts provide consultation and expert testimony analyzing the competitive effects of horizontal and vertical mergers and joint ventures across the healthcare sector. For this work, our experts account for the unique characteristics of the healthcare industry that shape competitors’ behaviors and incentives, utilize key healthcare data, and rely on sound economic theory to define product and geographic markets, assess the competitive constraints of entry and expansion, consider the impact of insurance and regulatory oversight on market dynamics, and quantify the cost reductions and quality enhancements that are only achievable through the proposed merger or joint venture.

Engagements

  • 01
    European Commission clears Cooper’s acquisition of Viatris’ European OTC business
    The transaction involved a number of horizontal overlaps in areas including antiseptics and disinfectants, laxatives, warts and corns, joint and muscular pain,...
    View engagement
  • 02
    Kevin Murphy testifies in successful healthcare technology merger
    CRA consultants were retained to provide economic assistance to UnitedHealth Group (UHG), a vertically integrated healthcare insurance company, and Change...
    View engagement
  • 03
    Phoenix Group’s acquisition of a part of McKesson Europe cleared
    On September 30th, 2022, the French Competition Authority (ADLC) cleared the acquisition of OCP Repartition, subsidiary of McKesson Europe, by Phoenix Group...
    View engagement

Subscribe to receive our latest Insights.

Subscribe